Latest News

‘Silver Streamers’ More Amenable To Advertising, Says DeepIntent-Roku Study

This post may contain affiliate links and we may earn a commission. Learn more

According to a new study from DeepIntent and Roku, so-called ‘silver streamers’ are more amenable to advertising than the general public, and pharmaceutical ads could be better targeted.

The importance of the use of advertising in the world of streaming has never been clearer. While many services charge a monthly subscription cost, most of them also now offer a ‘with ads’ tier to subsidize the cost.

There are also plenty of services that manage to completely offset the subscription cost through the use of ads. It is now even possible for consumers to get a TV for free, again, thanks to the popular and profitable ad-supported model.

According to a new study, ‘silver streamers’ (those aged 50 and above that use streaming services) are “an important demographic for pharmaceutical advertisers.” The report, titled Silver Streamers: A Golden Opportunity for Pharma Advertisers on CTV, draws its findings from a survey of 3,000 U.S. adults across every age group.

The survey found that 79% of adults 50 and over use streaming services, and that 66% prefer advertising-based video-on-demand (AVOD) services. This is the same model that’s commonly used to reduce or completely offset the cost of a subscription, and it is this statistic that’s being used to suggest those over 50 are “more amenable to advertising than the general population.”

The research paper also suggests that existing advertising on streaming services doesn’t accurately target the right type of consumer.

For example, the study found that 23% of patients 50+ said the pharmaceutical ads they see on streaming services were not relevant to their lives. This is in comparison to 40% for patients under 50.

According to Eric Lloyd, Head of Industry, Health, at Roku, “There is a tremendous opportunity to reach people over 50 in streaming environments, which offer much more than traditional TV in terms of impacting the patient journey and driving script lift.” Lloyd added, “The survey results only confirmed that it’s paramount for pharma advertisers to capitalize on this paradigm shift.”

Advertising aside, the survey also found that 96% of cord-cutters aged 50 and over were generally happy with their decision to cancel their cable/satellite TV service.

John Finn
Want to stay up to date on all our latest news and guides? Sign up to the Streaming Better newsletter.
John Finn

By John Finn

John Finn is the Founder and Editor of Streaming Better, a platform created in 2019 to help consumers navigate the complicated live TV streaming and subscription service market.

John has been covering technology for various online publications since 2014. After originally covering the wider tech industry as a writer and editor, John now spends his time focusing on the emerging video-streaming market, including live TV streaming, SVOD, AVOD, FAST, and TVOD services.

In a bid to keep up to date on the industry, John actively subscribes to multiple streaming services at the same time. However, John continues to advocate that the best approach for consumers is to rotate between streaming services as needed.

A Psychology graduate from England, who now lives in the US, John previously worked in the aviation industry as an airline reviewer. While reviewing airlines isn't quite the same as reviewing devices and streaming services, John brings the same analytical eye to all of his reviews and industry analysis, along with a special emphasis on what's best for the consumer.

Connect with John
X: @J_Finns

Leave a Reply

Streaming can be frustrating but please be respectful and avoid personal information. All comments are moderated according to our comment policy.